Vo to focus on product development to accelerate ComputChem’s continued growth

November 15, 2021, Baltimore, MD – ComputChem, a technology company building next-generation platform solutions for in silico covalent drug discovery design and lead optimization, today announced the hiring of Quynh (Q) Vo, a chemical engineer, as Applications Scientist.

Prior to joining ComputChem, Vo was as an ORISE fellow with the U.S. Food and Drug Administration, working on a variety of projects in collaboration with the University of Maryland School of Pharmacy.

Vo’s work involves the study of how opioids interact with their molecular targets and the development of computational protocols to predict residence times using advanced molecular simulations.

Her high-profile publications in Nature Communications and JACS Au continue to have a direct impact on the fundamental understanding of how opioids work, helping to pave the way for in silico efforts to address the nation’s opioid crisis.

In her role as Applications Scientist with ComputChem, Vo will support current and new product development efforts to accelerate the company’s growth.

“Q’s solid academic and research background in chemical engineering and computational modeling will enable us to move faster in product development,” said Ken Malone, an executive officer with ComputChem. “Q will be a major part of our efforts to drive continued advances in our iTitrate technology that enables the accurate prediction of reactive amino acid sites to assist the growing need of a targeted covalent drug discovery approach.”

Vo earned a BS from Cal Poly Pomona and a PhD from the University of California, Irvine, both in Chemical Engineering. As a NSF Graduate Research fellow, her PhD thesis used molecular dynamic simulations in conjunction with experimental work to clarify the processes involved in solvent extraction systems to improve the efficiency of recycling radioactive materials from spent nuclear fuel.

Vo has authored and co-authored an array of peer-reviewed articles; served as an academic lecturer in chemical engineering courses; and has presented at numerous national and international conferences.

About ComputChem:
ComputChem is a technology company building next-generation platform solutions for in silico covalent drug discovery design and lead optimization. ComputChem is an Early Charm Drug Design portfolio company. Learn more: Homepage

Media Contact:
Ken Berlack